Jpmorgan Chase & CO Avid Bioservices, Inc. Call Options Transaction History
Jpmorgan Chase & CO
- $1.22 Trillion
- Q3 2024
Call Options
0 transactions
| Quarter | Operation | Price Per call | calls change | calls Held | SEC Form |
|---|
Others Institutions Holding CDMO
# of Institutions
183Shares Held
67.8MCall Options Held
89.9KPut Options Held
118K-
Black Rock Inc. New York, NY5.11MShares$62.8 Million0.0% of portfolio
-
Israel Englander Millennium Management LLC | New York, Ny4.19MShares$51.5 Million0.02% of portfolio
-
Vanguard Group Inc Valley Forge, PA3.85MShares$47.3 Million0.0% of portfolio
-
Steven Cohen Point72 Asset Management, L.P. | Stamford, Ct3.82MShares$46.9 Million0.12% of portfolio
-
Altra Vue Capital, LLC Bellevue, WA3.8MShares$46.7 Million4.48% of portfolio
About Avid Bioservices, Inc.
- Ticker CDMO
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 62,167,500
- Market Cap $765M
- Description
- Avid Bioservices, Inc., a contract development and manufacturing organization, provides process development and current good manufacturing practices (CGMP) clinical and commercial manufacturing services focused on biopharmaceutical drug substances derived from mammalian cell culture. The company produces monoclonal antibodies and recombinant pro...